In Re Morrell

684 A.2d 361, 1996 D.C. App. LEXIS 231, 1996 WL 626250
CourtDistrict of Columbia Court of Appeals
DecidedOctober 28, 1996
Docket95-BG-1794
StatusPublished
Cited by29 cases

This text of 684 A.2d 361 (In Re Morrell) is published on Counsel Stack Legal Research, covering District of Columbia Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Morrell, 684 A.2d 361, 1996 D.C. App. LEXIS 231, 1996 WL 626250 (D.C. 1996).

Opinion

FERREN, Associate Judge:

The Board on Professional Responsibility concluded that Michael X. Morrell, respondent, violated several provisions of the Code of Professional Responsibility, including: Disciplinary Rule (DR) 1-102(A)(3) (illegal acts involving moral turpitude); DR 1-102(A)(4) (dishonest, deceitful, or fraudulent conduct); DR 9-103(A) (misappropriation of client funds); and DR 9-103(B) (failing to keep complete records and to account for client funds). 1 The Board recommended that this court impose the ultimate sanction of disbarment. Morrell makes four arguments for rejecting the Board’s report and recommendation: (1) the Bar Counsel’s initial complaint contained an inadequate oath under D.C.Code § ll-2503(b) (1995 Repl.) because it was not based on personal knowledge; (2) the delay in filing and prosecuting the complaint violated Morrell’s Due Process rights; (3) the Hearing Committee’s failure to issue its report within the 60 days required by D.C. Bar R. XI § 9(a) requires dismissal of the complaint; and (4) the Board’s report failed to explain adequately why the Hearing Committee (whose findings were adopted by the Board) rejected the testimony of one of Morrell’s witnesses. We hold that bar counsel’s complaint under oath need not be based on personal knowledge but may be based on information and belief, that Morrell suffered no actual prejudice from the several claimed delays in the proceedings, and that the Hearing Committee’s findings, which the Board adopted, as well as the Board’s conclusions, were adequately explained and amply supported by the testimony and documents in the record. We adopt the Board’s proposed *363 sanction of disbarment for Morrell’s flagrant violations of the rules governing attorney conduct.

I.

The Hearing Committee found that Mor-rell engaged in a pattern of misconduct in the course of his legal representation of Labora-toires Besins Iscovesco (Lab Besins), a French pharmaceutical company, and its United States affiliate, LaSalle Laboratories, Inc. (LaSalle), between 1983 and 1990. The Board concluded that the findings of fact in the Hearing Committee’s report were supported by substantial evidence in the record. See In re Smith, 403 A.2d 296, 302 (D.C. 1979). The series of events culminating in the charges before us can be summarized as follows:

In 1983, while an attorney at Warner & Stackpole, Morrell began representing Lab Besins, which was interested in marketing two drugs in the United States that it was successfully selling in France. From the outset, Morrell misrepresented to Lab Besins that he and his firm had the necessary experience to obtain approval of the drugs by the Food and Drug Administration (FDA). Shortly thereafter, Morrell left Warner & Stackpole but continued to represent Lab Besins as a sole practitioner. He agreed with Antoine Besins, who was in charge of Lab Besins’ foreign operations throughout the time period at issue in this case, that Lab Besins would pay him $300,000 for submitting the drug applications to the FDA, exclusive of the costs of clinical trials that might become necessary.

In December 1984, Morrell joined the law firm of Akin, Gump, Strauss, Hauer & Feld (Akin, Gump); payments due under his retainer agreement with Lab Besins were subsequently forwarded to Akin, Gump.

After learning from the FDA in 1985 that clinical trials would be necessary to win approval for the drugs, Morrell proposed to Lab Besins that a consulting firm he owned and controlled, the Georgetown Group, be used to coordinate payments for the trials. Lab Besins was to pay the Georgetown Group for conducting the trials, but none of the money sent to the Georgetown Group was intended to compensate Morrell in any manner. By letter, Morrell informed Lab Besins that the total budget would be $300,-000; however, between 1985 and 1988, he sent invoices to Lab Besins for slightly over $1,000,000, claiming that the prior budget was inadequate to complete the trials and navigate the approval process. The invoices to Lab Besins all indicated that the money was for clinical trials. Unknown to Lab Be-sins, however, Morrell spent almost half the $1,000,000 on personal expenses. (Morrell never provided Lab Besins with any accounting of the funds sent to the Georgetown Group to conduct the clinical trials.) Akin, Gump knew nothing about the billing arrangement Morrell established by using the Georgetown Group; nor was it aware that Morrell kept a large amount of the funds for his own use.

In 1988, Morrell, with the help of William Bologna, a friend who ran a public relations firm with significant experience in the pharmaceutical industry, negotiated a Co-Marketing Agreement between Lab Besins and the pharmaceutical company Schering-Plough. Schering-Plough agreed to make an initial investment of $7.5 million to facilitate approval and marketing of the drugs in exchange for a portion of the revenues. Under the agreement, if the FDA had not approved one of the drugs by June 30, 1990, or if both of the drugs were not approved by June 30, 1991, Schering-Plough would take over the approval and marketing process, and Lab Besins would receive only a royally on all sales, a much less lucrative arrangement for Lab Besins. Morrell assured Lab Besins officials that the deadlines easily would be met.

Lab Besins created LaSalle to receive the Schering-Plough investment and conduct the approval and marketing operations. LaSalle was to be Lab Besins’ wholly owned subsidiary. Morrell misrepresented to Lab Besins that Schering-Plough required him to be in charge of LaSalle. Lab Besins, through Antoine Besins, agreed to make Morrell president and CEO of LaSalle, with the understanding that Morrell would wind down his work at Akin, Gump and join LaSalle full- *364 time by the end of 1988 or the beginning of 1989. Morrell, however, continued to have Akin, Gump bill LaSalle for his legal services, causing LaSalle (whose finances he controlled as president and CEO) to pay Akin, Gump approximately $400,000 between April 1988 and April 1990. Indeed, Morrell created two copies of some of the invoices: one copy went to Akin, Gump, indicating that the bill was for legal services; the other copy was sent to LaSalle, depicting the moneys owed as charges for use of office space.

Morrell also caused LaSalle to pay Bologna $300,000 as a finder’s fee for Bologna’s role in facilitating the agreement between Lab Besins and Schering-Plough. Morrell informed Antoine Besins that he was making the payment. Morrell did not tell Besins, however, that Bologna was going to pay Mor-rell $150,000. Furthermore, Morrell created two false invoices to Bologna to cover up the “kick-back” he received.

During that same time period, while Mor-rell was receiving a salary from Akin, Gump and billing his services to LaSalle, he caused LaSalle to pay himself well over $1,000,000 in direct compensation. Akin, Gump required all attorneys to turn over to the firm all compensation received for professional services; it also had a policy requiring attorneys to obtain firm approval before acquiring stock in a company that was a firm client.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Klayman
District of Columbia Court of Appeals, 2025
In re Edward T. Smith Bruce E. Gardner
District of Columbia Court of Appeals, 2023
In re Rachal, III
District of Columbia Court of Appeals, 2021
In re Green
136 A.3d 699 (District of Columbia Court of Appeals, 2016)
IN RE H. FRANKLIN GREEN
District of Columbia Court of Appeals, 2016
In re Andre P. Barber
128 A.3d 637 (District of Columbia Court of Appeals, 2015)
David D. Travers v. United States
District of Columbia Court of Appeals, 2015
In re Takisha Brown
112 A.3d 913 (District of Columbia Court of Appeals, 2015)
In re Thomas Fortune Fay
111 A.3d 1025 (District of Columbia Court of Appeals, 2015)
In re Omwenga
49 A.3d 1235 (District of Columbia Court of Appeals, 2012)
In Re Sibley
990 A.2d 483 (District of Columbia Court of Appeals, 2010)
In Re Slaughter
929 A.2d 433 (District of Columbia Court of Appeals, 2007)
In Re Thyden
877 A.2d 129 (District of Columbia Court of Appeals, 2005)
Attorney Grievance Commission v. Braskey
836 A.2d 605 (Court of Appeals of Maryland, 2003)
In Re Tidwell
831 A.2d 953 (District of Columbia Court of Appeals, 2003)
Attorney Grievance Commission v. Cafferty
831 A.2d 1042 (Court of Appeals of Maryland, 2003)
In Re Carlson
802 A.2d 341 (District of Columbia Court of Appeals, 2002)
In Re Bernstein
774 A.2d 309 (District of Columbia Court of Appeals, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
684 A.2d 361, 1996 D.C. App. LEXIS 231, 1996 WL 626250, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-morrell-dc-1996.